Patents by Inventor Christin Andersson

Christin Andersson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Fusion Proteins Having a Modulated Half-Life in Plasma
    Publication number: 20080274096
    Abstract: The present invention relates to fusion proteins and their use in enzymatic treatment of Alzheimer's disease patients. Said fusion protein comprises a component that cleaves the amyloid beta (Ab) peptide e.g. neprilysin, insulin degrading enzyme (IDE), another component that modulates the half-life in plasma e.g. the Fc portion of IgG or PEG; and a third component that connects the first two components.
    Type: Application
    Filed: October 2, 2006
    Publication date: November 6, 2008
    Applicant: ASTRAZENECA AB
    Inventors: Christin Andersson, Per-Ola Freskgard
  • New Method 706
    Publication number: 20080242590
    Abstract: The present invention relates fusion proteins and their use in enzymatic treatment of Alzheimer's disease patients. Said fusion protein has the formula M-A, capable of degrading amyloid beta peptide at one or more cleavage sites in its amino acid sequence, wherein M is a protein component that prolongs the half-life of the fusion protein, and A is a protein component that cleaves the amyloid beta peptide.
    Type: Application
    Filed: March 28, 2008
    Publication date: October 2, 2008
    Applicant: ASTRAZENECA AB
    Inventors: Christin Andersson, Per-Ola Freskgard